{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:27:18Z","timestamp":1787646438308,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["\u211626-15-00151"],"award-info":[{"award-number":["\u211626-15-00151"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["\u211626-15-00151"],"award-info":[{"award-number":["\u211626-15-00151"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Early detection of ovarian cancer remains challenging because of the lack of sensitive and reproducible blood-based biomarkers. A major challenge in plasma proteomics is the extremely wide dynamic range of protein concentrations, which prevents simultaneous detection of both high- and low abundance proteins and limits the identification of disease-associated signals. In this study, we applied a combined atomic force microscopy and mass spectrometry (AFM\/MS) approach to investigate how sample dilution affects plasma proteome coverage and the detection of differences between healthy donors and patients with stage I and stage III ovarian cancer. Plasma samples were analyzed at two dilution levels (1:100 and 1:10,000). At 1:100 dilution, a total of 235 proteins were identified across all samples, representing the union of all replicates and groups. The reproducible CORE proteome comprised 169 proteins in the Healthy group, 183 in the Stage I group, and 193 in the Stage III group. Differential analysis revealed distinct, non-overlapping protein sets at each dilution level. At 1:100 dilution, most altered proteins were decreased in patients and corresponded to major plasma components, including complement proteins and protease inhibitors. At 1:10,000 dilution, most altered proteins were increased and were predominantly immunoglobulin-related proteins, along with complement regulatory components. These findings show that sample dilution determines which fraction of the plasma proteome is observable. Here, proteome depth refers to the total number of non-redundant proteins accessible within the analytical workflow. When CORE sets from all groups were combined, 216 proteins were identified at 1:100 and 149 at 1:10,000, with 133 shared between the two dilution conditions. The higher dilution contributed 16 additional CORE proteins not detected in the 1:100 CORE union, increasing the combined CORE set to 232 proteins. Thus, higher dilution alone did not increase proteome depth, but provided complementary protein identifications that increased cumulative proteome depth when both dilution conditions were considered together. This effect reflects dilution-dependent selectivity in the composition of the detectable protein subset.<\/jats:p>","DOI":"10.3390\/ijms27177541","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"7541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood Plasma Analysis in Ovarian Cancer Patients Using an AFM\/MS Approach: Effect of Sample Dilution on Proteome Depth"],"prefix":"10.3390","volume":"27","author":[{"given":"Arina I.","family":"Gordeeva","sequence":"first","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Konstantinova","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3303-3657","authenticated-orcid":false,"given":"Tatiana A.","family":"Materova","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3688-4074","authenticated-orcid":false,"given":"Elizaveta E.","family":"Rybakova","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Ershova","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-0275","authenticated-orcid":false,"given":"Nikita E.","family":"Vavilov","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-4274","authenticated-orcid":false,"given":"Victor G.","family":"Zgoda","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3217-9095","authenticated-orcid":false,"given":"Tatyana O.","family":"Pleshakova","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Archakov","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"284","article-title":"Ovarian Cancer Statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102074","DOI":"10.1016\/j.canep.2021.102074","article-title":"Ovarian Cancer Survival by Stage, Histotype, and Pre-Diagnostic Lifestyle Factors, in the Prospective UK Million Women Study","volume":"76","author":"Gaitskell","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Committee on Gynecologic Practice, and Society of Gynecologic Oncology (2017). Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk. Obstet. Gynecol., 130, e146\u2013e149.","DOI":"10.1097\/AOG.0000000000002299"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2013.07.094","article-title":"Diagnostic Performance of the Biomarkers HE4 and CA125 in Type i and Type II Epithelial Ovarian Cancer","volume":"131","author":"Kristjansdottir","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2018.08.025","article-title":"A Multicenter Clinical Trial Validating the Performance of HE4, CA125, Risk of Ovarian Malignancy Algorithm and Risk of Malignancy Index","volume":"151","author":"Lycke","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0046-1816582","article-title":"Diagnostic Performance of ROMA and Biomarkers in Ovarian Cancer: A Systematic Review of Sensitivity, Specificity, and Menopausal Influence","volume":"47","author":"Mirzaeva","year":"2026","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Englisz, A., Smycz-Kuba\u0144ska, M., and Mielczarek-Palacz, A. (2024). Sensitivity and Specificity of Selected Biomarkers and Their Combinations in the Diagnosis of Ovarian Cancer. Diagnostics, 14.","DOI":"10.3390\/diagnostics14090949"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e02826","DOI":"10.1016\/j.heliyon.2019.e02826","article-title":"Multi-Biomarker Panel Signature as the Key to Diagnosis of Ovarian Cancer","volume":"5","author":"Muinao","year":"2019","journal-title":"Heliyon"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-Spectrometric Exploration of Proteome Structure and Function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14789450.2014.901157","article-title":"Mass Spectrometry-Based Plasma Proteomics: State of the Art and Future Outlook","volume":"11","author":"Pernemalm","year":"2014","journal-title":"Expert Rev. Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117727190700200","DOI":"10.1177\/117727190700200005","article-title":"Proteomics and Mass Spectrometry for Cancer Biomarker Discovery","volume":"2","author":"Lu","year":"2007","journal-title":"Biomark. Insights"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13048-018-0460-6","article-title":"Mass Spectrometry-Based Proteomics Techniques and Their Application in Ovarian Cancer Research","volume":"11","author":"Swiatly","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/pr1008515","article-title":"On the Development of Plasma Protein Biomarkers","volume":"10","author":"Surinova","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jprot.2009.07.001","article-title":"The Dynamic Range Problem in the Analysis of the Plasma Proteome","volume":"73","author":"Hortin","year":"2010","journal-title":"J. Proteom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma Proteome Profiling to Assess Human Health and Disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12014-024-09477-6","article-title":"Neat Plasma Proteomics: Getting the Best out of the Worst","volume":"21","author":"Metatla","year":"2024","journal-title":"Clin. Proteom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jasms.2006.03.006","article-title":"Dynamic Range of Mass Accuracy in LTQ Orbitrap Hybrid Mass Spectrometer","volume":"17","author":"Makarov","year":"2006","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Thakur, S.S., Geiger, T., Chatterjee, B., Bandilla, P., Fr\u00f6hlich, F., Cox, J., and Mann, M. (2011). Deep and Highly Sensitive Proteome Coverage by LC-MS\/MS without Prefractionation. Mol. Cell. Proteom., 10.","DOI":"10.1074\/mcp.M110.003699"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"124046","DOI":"10.1016\/j.jchromb.2024.124046","article-title":"Optimizing and Integrating Depletion and Precipitation Methods for Plasma Proteomics through Data-Independent Acquisition-Mass Spectrometry","volume":"1235","author":"Zhou","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4155\/bio-2019-0145","article-title":"Plasma\/Serum Proteomics: Depletion Strategies for Reducing High-Abundance Proteins for Biomarker Discovery","volume":"11","author":"Lee","year":"2019","journal-title":"Bioanalysis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18097\/pbmc20247005273","article-title":"AFM-Fishing Technology for Protein Detection in Solutions","volume":"70","author":"Pleshakova","year":"2024","journal-title":"Biomed. Khim."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gordeeva, A.I., Valueva, A.A., Rybakova, E.E., Ershova, M.O., Shumov, I.D., Kozlov, A.F., Ziborov, V.S., Kozlova, A.S., Zgoda, V.G., and Ivanov, Y.D. (2023). MS Identification of Blood Plasma Proteins Concentrated on a Photocrosslinker-Modified Surface. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010409"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1021\/acs.jproteome.5c00758","article-title":"Advancing Plasma Proteomics for the Discovery of Ovarian Cancer Biomarkers","volume":"24","author":"Sarygina","year":"2025","journal-title":"J. Proteome Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141127","DOI":"10.1016\/j.bbapap.2026.141127","article-title":"MS Analysis of Proteins Concentrated on the Surface of AFM Chips from the Blood Plasma of Healthy Volunteers","volume":"1874","author":"Gordeeva","year":"2026","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cui, X., and Xie, Z. (2017). Protein Interaction and Na\/K-ATPase-Mediated Signal Transduction. Molecules, 22.","DOI":"10.3390\/molecules22060990"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0074-7696(08)60153-9","article-title":"Desmosomes: Intercellular Adhesive Junctions Specialized for Attachment of Intermediate Filaments","volume":"185","author":"Kowalczyk","year":"1998","journal-title":"Int. Rev. Cytol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","article-title":"Developmental Myosins: Expression Patterns and Functional Significance","volume":"5","author":"Schiaffino","year":"2015","journal-title":"Skelet. Muscle"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI27698","article-title":"Serine Protease HtrA1 Modulates Chemotherapy-Induced Cytotoxicity","volume":"116","author":"Chien","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20100046","article-title":"The Cutting Edge: Membrane Anchored Serine Protease Activities in the Pericellular Microenvironment","volume":"428","author":"Antalis","year":"2010","journal-title":"Biochem. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1753425910368447","article-title":"Review: Gp-340\/DMBT1 in Mucosal Innate Immunity","volume":"16","author":"Madsen","year":"2010","journal-title":"Innate Immun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e10427","DOI":"10.15252\/emmm.201910427","article-title":"Plasma Proteome Profiling to Detect and Avoid Sample-related Biases in Biomarker Studies","volume":"11","author":"Geyer","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.aan2507","article-title":"A Pathology Atlas of the Human Cancer Transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-Dependent Roles of Complement in Cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.celrep.2014.02.014","article-title":"Autocrine Effects of Tumor-Derived Complement","volume":"6","author":"Cho","year":"2014","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1097\/MS9.0000000000004192","article-title":"Venous Thromboembolism in Ovarian Cancer: Pathophysiology, Risk, and Management","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.26442\/18151434.2025.2.203324","article-title":"Cancer-Associated Thrombosis: Pathogenesis, Risk Factors, and Treatment. A Review","volume":"27","author":"Bilyalov","year":"2025","journal-title":"J. Mod. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.critrevonc.2018.04.005","article-title":"Paraoxonase-1 Activity in Patients with Cancer: A Systematic Review and Meta-Analysis","volume":"127","author":"Arenas","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Weber, F., Schueler-Toprak, S., Buechler, C., Ortmann, O., and Treeck, O. (2023). Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050944"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1143\/JJAP.45.4259","article-title":"High-Density and Highly Surface Selective Adsorption of Protein-Nanoparticle Complexes by Controlling Electrostatic Interaction","volume":"45","author":"Yamada","year":"2006","journal-title":"Jpn. J. Appl. Phys."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant Computational Platform for Mass Spectrometry-Based Shotgun Proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant Enables High Peptide Identification Rates, Individualized p.p.b.-Range Mass Accuracies and Proteome-Wide Protein Quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment","volume":"10","author":"Cox","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: The Universal Protein Knowledgebase in 2025","volume":"53","author":"Bateman","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:01:43Z","timestamp":1787644903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":44,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177541"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177541","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}